Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts
DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced the appointment of Robynn Sweet to the position of vice president, strategic accounts.
Prior to joining Assure, Ms. Sweet worked at Premier, Inc. serving as director of Group Purchasing Organization (“GPO”) sales for national accounts. Before that, Ms. Sweet was regional vice president of sales at HealthTrust where her efforts were instrumental in driving more than $100 million in corporate revenue. Ms. Sweet earned a Bachelor of Science in Nursing from the University of Texas Health Science Center.
“We are excited for Robynn to join our team and lead Assure’s efforts in building new business development opportunities with our GPO partners. Robynn has twelve years of experience working for national healthcare GPOs including Premier, HealthTrust and Amerinet, where she gained valuable domain knowledge, expertise and contacts that Assure previously lacked,” said John A. Farlinger, Assure’s executive chairman and CEO. “Robynn’s hiring reflects Assure’s 2022 strategy of continuing to focus our business on GPO and facilities-based contracts.”
On her appointment, Ms. Sweet commented, “Safety, service and improved clinical outcomes are the cornerstones of Assure's mission, and a major driver of the Company's growth. I am eager to hit the ground running and look forward to making an impact across the organization.”
About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: expectations with respect to the Company’s growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
Released August 23, 2022